2月27日，华测检测盘中上涨2.01%，截至09:48，报16.27元/股，成交1.09亿元，换手率0.47%，总市值 273.80亿元。 资金流向方面，主力资金净流入1190.66万元，特大单买入436.10万元，占比3.99%，卖出0.00元，占比 0.00%；大单买入2665.62万元，占比24.39%，卖出1911.06万元，占比17.49%。 分红方面，华测检测A股上市后累计派现11.61亿元。近三年，累计派现5.19亿元。 机构持仓方面，截止2025年9月30日，华测检测十大流通股东中，香港中央结算有限公司位居第一大流 通股东，持股2.89亿股，相比上期增加2081.59万股。易方达创业板ETF（159915）位居第三大流通股 东，持股2988.96万股，相比上期减少503.01万股。南方中证500ETF（510500）位居第四大流通股东， 持股2450.01万股，相比上期减少44.44万股。嘉实新兴产业股票（000751）位居第七大流通股东，持股 1377.25万股，相比上期减少221.56万股。嘉实核心成长混合A（010186）退出十大流通股东之列。 声明：市场有风险，投资需谨慎。本文基于第三 ...

相关上市企业：广电计量（002967）、华测检测（300012）、远方信息（300306）、谱尼测试 （300887）、信测标准（300938）、西测测试（301306） 内容概要：近年来，我国电磁兼容监管体系持续完善，监管范畴已从传统消费电子、家电，逐步覆盖至 汽车、新能源、医疗、轨道交通、航空航天等多元领域，强制性认证（CCC）、自愿性认证（CQC） 及行业专项标准不断扩容，新增品类与标准更新直接拉动测试需求增长，同时，出口型企业为满足欧 盟、美国、日本等国际市场的EMC法规要求，对具备国际互认能力的国内第三方测试机构服务需求显 著提升，行业合规需求也从"被动达标"向"主动布局"转变，共同推动行业规模稳步扩张，据统计，2025 年我国电磁兼容性（EMC）测试行业市场规模达69.28亿元，同比增长11.7%，其中，电磁兼容检测服务 约占76.13%，电磁兼容检测设备约占23.87%。 关键词：电磁兼容性（EMC）测试行业市场政策、电磁兼容性（EMC）测试行业产业链、电磁兼容性 （EMC）测试市场规模、电磁兼容性（EMC）测试竞争格局、电磁兼容性（EMC）测试发展趋势 相关企业：苏州泰思特电子科技有限公司、上 ...

中国质量新闻网讯 据海口市市场监督管理局网站消息，2026年1月-2026年2月，海口市市场监督管理局委托华测检测认证集团股份有限公司对全市流通领域 的卫生用纸制品产品进行了市级监督抽查。本次共抽查8批次产品，8批次产品全部合格，不合格检出率为0%。 2025年海口市卫生用纸制品产品监督抽查质量合格产品 | 序 产品名称 | 等级 | 规格型号 | 生产日期 | 被抽检企业/所在地 | | --- | --- | --- | --- | --- | | 号 | | | | | | 1 清风牌卫生纸 | 优等 | 138mm×100mm（4层）净含量：118克/ | 2025 07 | 海南旺佳旺商贸有限公司新城吾悦店/海南省海口市龙华区城西镇迎宾 | | | 品 | 卷，10卷/提 | 29/- | 路18号海口吾悦广场B1004号铺面 | | 2 清风牌卫生纸 | 优等 | 规格：138mm×150mm（4层）×10卷 净含 | 2025 10 | 海南省福联顺商贸有限公司鹏晖店/海南省海口市美兰区和平大道20号 | | | 品 | 量：750克/提 | 23/- | 鹏晖广场1-3层 | | 3 心相印牌 ...

（来源：淘金ETF） 1. 先导智能（300450） 作为高端智能装备领域的重要企业，公司在精密制造与自动化方案上具备较强竞争力，业务覆盖新能源 装备与电子制造装备。公司为PCB行业提供高精度裁切、成型、检测等自动化生产设备，助力高多层 板、HDI板等高端产品提升生产效率与良率。随着AI服务器与数据中心建设加速，PCB行业对高端制程 装备需求持续提升，公司凭借在运动控制、精密集成方面的技术积累，不断优化适配通信板、汽车板的 装备方案。相关产品可满足头部PCB厂商扩产与技术改造需求，在电子制造装备国产化过程中保持稳定 迭代，与行业高端化、智能化发展方向高度契合，为PCB产业链提供可靠的制程装备支持，在高端制造 环节形成自身独特的行业价值。 2. 方正科技（600601） 公司背景具有国资属性，在电子信息领域拥有长期产业积淀。公司主营印制电路板的研发、生产与销 售，产品覆盖通信基站板、工业控制板、消费电子板等，广泛应用于网络设备、工业终端、智能家居等 场景。企业持续推进PCB产线工艺升级，重点提升高多层板与高频高速板占比，强化产品可靠性与信号 传输性能，以适配5G通信、工业互联网等领域的升级需求。在行业向集中化、 ...

证券代码：300012 证券简称：华测检测 公告编号：2026-002 华测检测认证集团股份有限公司 关于公司第四期员工持股计划完成非交易过户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）分别于 2025 年 11 月 3 日、2025 年 11 月 28 日召开第六届董事会第二十七次会议、2025 年第一次临时 股东会，审议通过了华测检测认证集团股份有限公司第四期员工持股计划（草案） 及摘要》《华测检测认证集团股份有限公司第四期员工持股计划管理办法》等相 关议案。目前，本次员工持股计划已完成非交易过户，现将相关进展情况公告如 下： 一、员工持股计划股份过户情况 本期员工持股计划的股份来源为公司回购专用账户的华测检测 A 股普通股股 票。 公司已在中国证券登记结算有限责任公司深圳分公司开立了本期持股计划 专用证券账户，证券账户名称为"华测检测认证集团股份有限公司－第四期员工 持股计划"，证券账户号码为 08995*****。 2026 年 2 月 25 日，公司收到中国证券登记结算有限责任公司深圳分公司 ...

Core Insights - The report emphasizes the strong growth potential in the testing services industry, particularly driven by emerging sectors such as commercial aerospace and new technologies [4][6] - The testing services sector is closely linked to macroeconomic growth, with a projected global market size of approximately 2.3 trillion RMB by 2024, reflecting a CAGR of about 6% from 2021 to 2024 [4][24] - In China, the testing services market is expected to reach around 487.6 billion RMB by 2024, with a CAGR of approximately 10.5% from 2015 to 2024, indicating a robust growth trajectory [5][24] Industry Overview - The testing, inspection, and certification (TIC) industry serves various sectors including consumer goods, industrial products, and pharmaceuticals, covering all stages from R&D to production and distribution [16][24] - The industry is characterized by a large market space and stable growth, with demand closely tied to macroeconomic trends and government regulations [20][24] - Emerging technologies such as AI, electric vehicles, and commercial aerospace are expected to create new testing demands, raising the entry barriers for new players [6][20] Company Performance - The report analyzes 19 listed companies in the testing services sector, highlighting their revenue and profit performance, with notable companies including Huace Testing, Guangdian Measurement, and Su Testing [2][11] - In the first three quarters of 2025, the testing services sector in China reported a revenue of 30.4 billion RMB, a decline of 7% year-on-year, but a growth of 3% when excluding companies heavily involved in medical testing [5][57] - Leading companies such as Huace Testing, Guangdian Measurement, and Su Testing demonstrated superior performance, with revenue growth rates of 7%, 12%, and 9% respectively, significantly outpacing the industry average [5][62] Market Dynamics - The testing services market is experiencing a structural shift, with a trend towards consolidation as larger firms gain market share and smaller firms face challenges [44][50] - The report notes that the majority of testing institutions in China are small and micro-sized, which limits their ability to withstand economic pressures [50][51] - Government policies are increasingly supporting the marketization and consolidation of testing institutions, aiming to enhance the overall quality and efficiency of the industry [51][53] Financial Metrics - The report indicates that the average gross margin for the testing services sector has improved, reaching 26.2% in the first three quarters of 2025, reflecting a recovery in profitability [63] - The accounts receivable turnover days have increased from 90 days in 2019 to 176 days in 2025, indicating a slowdown in cash flow and potential credit risks within the industry [67][68] - The report highlights that the proportion of accounts receivable in relation to revenue has risen to 50%, suggesting increasing challenges in managing receivables [71]

Investment Rating - The report recommends focusing on leading companies in the testing service industry, particularly those with strong capital, management, and research capabilities, such as Huace Testing, Guangdian Measurement, and Sutest [7] Core Insights - The testing service industry is closely related to macroeconomic growth, with significant market space and stable growth. The global testing service market is projected to reach approximately 2.3 trillion RMB by 2024, with a CAGR of about 6% from 2021 to 2024 [4][24] - China's testing service industry is expected to outpace GDP growth, with a projected market size of around 487.6 billion RMB in 2024, reflecting a CAGR of approximately 10.5% from 2015 to 2024 [5][24] - The industry is experiencing a structural shift, with emerging sectors such as AI, new energy vehicles, and commercial aerospace driving new demand for testing services [6][33] Summary by Sections Industry Overview - The testing, inspection, and certification (TIC) industry serves various sectors, including consumer goods, industrial products, and pharmaceuticals, covering all stages from R&D to production and distribution [16] - The demand for testing services is highly correlated with macroeconomic trends, with growth driven by global trade, increasing quality and safety standards, and stricter regulations [20][24] Market Performance - In 2025, the testing service sector in China reported revenues of 30.4 billion RMB, a year-on-year decline of 7%. Excluding companies with high medical testing proportions, the sector saw a 3% growth [5][57] - Leading companies like Huace Testing, Guangdian Measurement, and Sutest outperformed the industry average, with revenue growth rates of 7%, 12%, and 9% respectively in the first three quarters of 2025 [57][62] Emerging Opportunities - New technologies and industries, such as low-altitude economy and semiconductor sectors, are rapidly developing, creating new testing service demands. The investment threshold for laboratories in these areas is significantly higher than traditional sectors [6][33] - The report emphasizes the importance of focusing on leading companies that possess brand, capital, and management advantages to capitalize on these emerging opportunities [6][7] Competitive Landscape - The testing service market in China is characterized by a large number of small and medium-sized enterprises, with over 96% of testing institutions being micro-sized, which poses risks due to their limited capacity to withstand economic fluctuations [50][51] - The report predicts a trend towards consolidation in the industry, with resources increasingly concentrating in leading firms as smaller entities face challenges [50][51]

Group 1 - The company emphasizes its ability to leverage industry policy opportunities and has a comprehensive range of testing qualifications and extensive business layout, which supports solid business implementation and capacity release [2] - The company's operating performance has shown steady growth in recent years, with all operational data accurately reflecting its development achievements, countering claims of "paper data" [2] - As a leading enterprise in the industry, the company focuses on enhancing operational efficiency, accelerating the release of emerging businesses, and strengthening internal collaboration to create differentiated advantages [2] Group 2 - The company is successfully converting industry dividends into operational effectiveness and asserts that it does not underperform relative to the industry average [2] - The capital market performance is influenced by multiple factors, including macroeconomic conditions and market sentiment, and short-term fluctuations do not represent the company's long-term value [2] - The company encourages rational perspectives on market volatility and advises caution regarding investment risks [2]

Core Viewpoint - The company Huace Testing (300012) forecasts a net profit increase of 10%-11% for 2025, driven by successful overseas acquisitions, ongoing development in emerging businesses, and optimized corporate governance, amidst significant fluctuations in market capital flows [1][2]. Financial Performance - The company expects a net profit attributable to shareholders for 2025 to be between 1,012.77 million yuan and 1,021.49 million yuan, representing a year-on-year growth of 10%-11%. The fourth quarter is projected to see a net profit increase of 15%-20% [2]. Project Advancement - In the second half of 2025, the company completed acquisitions of SafetySA in South Africa, Emicert in Greece, and MIDAC laboratory in France, with successful integration into the company’s financials in the fourth quarter. However, the immediate contribution to earnings is limited, with long-term growth potential expected to gradually materialize [3]. Business Development - The company continues to focus on strategic areas such as semiconductor testing, low-altitude economy, and pharmaceutical testing. In semiconductor testing, it provides reliability validation services for AI computing chips, while in pharmaceutical testing, it is advancing technology reserves and qualification applications related to new viruses. These business segments are expected to increase their revenue share [4]. Corporate Structure and Governance - On December 25, 2025, the company completed a board of directors' election, with Wan Feng appointed as chairman. New committees, including a strategy and ESG committee, were established to enhance governance efficiency [5]. Capital Movements - Recent trading data indicates significant capital fluctuations, with a net outflow of 58.49 million yuan on January 20, 2026, and a further net outflow of 37.72 million yuan on January 26, 2026. These dynamics may reflect short-term market sentiment [6].

Core Viewpoint - The company has launched its fourth employee stock ownership plan, which is progressing as scheduled [2] Group 1 - The fourth phase of the employee stock ownership plan was introduced in November 2025 [2] - The plan is currently being implemented according to the established timeline [2]